"1st Regional Ukrainian Congress on Controversies in Neurology"




"Roche Ukraine"

UL. Sahaidachny, 33,

3rd floor 04070 Kiev

Telephone: (044) 354-30-40

Fax: (044) 354-30-41

E-mail: kiev.office@roche.com

Website: http://www.roche.ua/



100 Cyberonics Boulevard

Houston, Texas 77058

Tel: +1.800.332.1375

Fax: +


Mfg by Cyberonics, Inc.

100 Cyberonics Boulevard

Houston, Texas 77058

Tel: +1.800.332.1375

Fax: +


Zavalna street,  26

02132 Kyiv

Tel: +38 044 221 21 97

Fax: +38 044 221 21 98



Boulevard of Ivan Lepse, 8

Kyiv 03124

Tel : +38 044 281 2333




+38 044 207-73-50




street Skryabin, 54, Sumy, 40022

+38 0542 241661

+38 0542 672321




Ranbaxy Pharmaceuticals Ukraine LLC

a SUN PHARMA company

02121 Kyiv

175 Kharkivske shosse

+380-44 371 77 21/23

+380-44 371 77 22



Sanofi Ukraine

48-50A, Zhylyanska Street, 01033 Kyiv, Ukraine

Tel. +38 (044) 354 20 00

Fax. +38 (044) 354 20 01


Sanofi Ukraine

48-50A, Zhylyanska Street, 01033 Kyiv, Ukraine

Tel. +38 (044) 354 20 00

Fax. +38 (044) 354 20 01


The company F. Hoffmann-La Roche Ltd, widely known as Roche, was founded in 1896 in Basel, Switzerland by Fritz-Hoffman, who together with his wife Adel La Roche gave a name to the company. At the very beginning of the company`s existence, Fritz Hoffmann organized a network of agents in other countries, such as Italy, France, Germany, England, the USA, Japan and Russia. In 1897 Roche employed about 50 people, and in 1914 the number of employees in different countries exceeded 700. Roche gradually became a company producing a wide range of products. In particular, it consisted of subdivisions of pharmaceuticals, vitamins, fine chemicals, diagnostic equipment, which represented a full range of means for prevention, diagnosis and therapy. The emphasis on research has led to a powerful breakthrough in the field of pharmacy and universal recognition of the company. Four major research centers were organized in Basel (Switzerland), Nutley (USA), Velvin Garden City (England) and Kamakura (Japan) to provide Roche with higher-quality products and technologies. Roche has been making a significant contribution to the world health care for more than 100 years. Twenty-four Roche medicines including vitally important antibiotics, antimalarials and chemotherapeutic drugs, are included in the WHO List of Essential Medicines.

In 2014 the staff of the Roche group of companies amounted to more than 88,500 people, investment in research and development was 8.9 billion Swiss francs, and sales amounted to 47.5 billion Swiss francs. Roche owns Genentech Inc., the United States and a controlling stake of Chugai Pharmaceutical Co., Ltd., Japan.




LivaNova is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. Our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems.







LivaNova is a market leader with a workforce of more than 4,500 employees worldwide. We are headquartered in London (UK) and maintain a presence in more than 100 countries.















Company Meditrade Ltd. Was established in 1991 in Slovakia by Mr. Pavel Bohdal who is the General Manager of company till present.

Nowadays Meditrade holds one of the leading position at the market of distributions and counselling of medical products for non-pharmacological treatment of cardiovascular diseases.








ASINO PHARMA START is a modern pharmaceutical company in the field of development and production of high-tech generic drugs with additional properties. Today, the company occupies the 8th place in the rating of Ukrainian manufacturers of pharmaceutical products.

The provision of international quality standards is the basis of all the production and business processes of the ASINO PHARMA START company. For the production of highly effective medicines, we use our own production site in the city of Kiev - a plant certified according to the standards of good manufacturing practice GMP, and a research laboratory for the development of new drugs.










Number 1 in Ukraine for the vibrobitvtva oath and sale of ready-made lakar products in packages. Zavdjaky vysokomu rivnyu vibrochnichoi kul'turi, lagatornochnogo bezdogannoї reputatsiі vyrobnika yakіshnikh bespechchnikh ta efektivnykh likar'skikh zasobiv i viyskoi sotsіalnogo sostochnosty nashoi produkcii, mi deserve a high riven doviri lіkarіv, provizorіv, patіієntіv ta іnshih uchasnikiіv pharmaceutical market before the trade mark "Darnytsya."




Kusum Pharm is a modern enterprise for the production of non-sterile medicines in solid dosage and liquid non-sterile dosage forms for oral administration.

The construction of the Kusum Farm plant began in 2005 after the acquisition of an object of unfinished construction in the city of Sumy. In August 2009 the plant was put into operation.

The basis of the company's success is the quality, efficiency and safety of manufactured pharmaceutical products, a high level of quality standards and standards in business, an appropriate level of service for end-users.










Аn international pharmaceutical company specializing in the production of drugs in the field of neurology, cardiology, pediatrics, gastroenterology, otorhinolaryngology, dermatology.




We are engaged in the sales and distribution of generic medicines in the healthcare system of Ukraine. We are present in each region of the country with a dedicated, experienced and professional field force.


The key therapeutic areas that we are present in include pain/NSAIDs, anti-infective, respiratory, cardiovascular, gastrointestinal, urology, over-the-counter (OTC) and anti-retroviral (ARV). We have built strong brands in the market like Ketanov, Faringosept, Cifran and Candesar. Our brands occupy leading positions in their respective segments.










Sanofi Ukraine is a part of Sanofi, a global healthcare company, committed to prevention and treatment of disease and to supporting populations throughout the world.

The company has been operating in Ukraine for more than 20 years and is ranked #1 among international pharmaceutical companies in the Ukrainian market ⃰.

 The wide portfolio of Sanofi Ukraine includes original and generic products to treat diabetes, cardio-vascular, gastrointestinal and oncology diseases, central nervous system disorders, rare diseases and many others. A number of well-known consumer products and vaccines complement this portfolio.

Sanofi’s involvement into the healthcare of Ukraine goes beyond just providing quality treatments. The company initiates information and education programs to prevent diseases and enhance the life of Ukrainians. Among them – the program “Act for Diabetes”, projects on cancer early detection, campaigns to support people with epilepsy and rare diseases etc.

 ⃰according to Proxima Research, Market turnover (retail+hospital) November 2016 YTD





Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. We help people with debilitating and complex conditions that are often difficult to diagnose and treat. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world.

Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, we also established ourselves as a leader in the field of multiple sclerosis. In 2016, our focus expanded to include Sanofi’s programs in oncology and immunology




Technical organizer

« Projects Inn » LLC


Charitable foundation Research Innovations in Medicine “RIMON”

Ukraine, Kyiv, 01001, Business centre «Panorama»

Velyka Zhytomirska st., 20, 9 fl.

Tel/Fax: +380445375277,

E-mail: foundation@rimon.in.ua ,

www.rimon.in.ua/cony /2017